Online Ahead of Print


On the Paclitaxel Meta-Analysis: A Conversation With Konstantinos Katsanos, MD

Dr. Katsanos discusses the methods and findings of his group’s meta-analysis, the patient-level data presented in response, and potential next steps.



BD Issues Statement in Response to FDA’s Letter Announcing Long-Term Data Review of Paclitaxel Devices Used in PAD

March 22, 2019 -- BD (Becton, Dickinson and Company) has issued a statement regarding the recent FDA letter that announced the preliminary review of long-term data on the use …

Merit’s Embosphere Microspheres Receive Expanded Indication to Control Bleeding/Hemorrhaging in the Peripheral Vasculature

March 22, 2019 -- Merit Medical Systems, Inc. announced the FDA clearance of an expanded indication for its Embosphere microspheres for the embolization of blood vessels to oc…

Endovenous Therapy Procedures for Lower Extremity Venous Disease Increasingly Performed by Nonvascular Specialties

March 20, 2019 -- A recent study of Medicare beneficiaries found that endovenous therapy (EVT) procedures are being increasingly performed by physicians not traditionally asso…

Endospan's Nexus Stent Graft System Receives CE Mark Approval

March 19, 2019 -- Endospan announced that it has received European CE Mark approval for its Nexus stent graft system for the endovascular repair of aortic arch disease compris…

UK Regulator Appoints Expert Advisory Group to Review Paclitaxel Devices in PAD

March 20, 2019 -- The United Kingdom Medicines and Healthcare Products Regulatory Agency (MHRA) announced the formation of an independent Expert Advisory Group (EAG) to review…

Six-Month "On-Medication" Results Presented From RADIANCE-HTN SOLO Trial

March 17, 2019 -- ReCor Medical, Inc. announced the 6-month "on-medication" results from the RADIANCE-HTN SOLO clinical trial of the company's Paradise renal den…

Click here for more News coverage

Current Supplement

Sponsored by GORE & ASSOCIATES

Looking at the Full Scope of PAD

Cases, Techniques, and Economic Considerations for Complex Disease.

Current European Supplement

Sponsored by BIOTRONIK

Maximizing Outcomes. Minimizing Burden.

How to React in the SFA

Paclitaxel In PAD

Device Guide

This Device Guide offers a searchable, comprehensive listing of the available vascular interventional devices in the United States.


Featured Center



Vascular Market Price  Change
Abbott Laboratories $77.97  -2.61%
AstraZeneca PLC $42.59  -0.84%
Avinger $0.88  -4.36%
Becton Dickinson and Co $240.12  -2.16%
Boston Scientific Corporation $37.30  -2.23%
Cardinal Health $48.64  -3.03%
Cardiovascular Systems Inc. $38.66  -3.95%
Edwards Lifesciences Corp. $188.99  -1.64%
Endologix Inc. $6.71  -6.42%
Vascular Market Price  Change
Johnson and Johnson $136.91  -0.86%
Medtronic, Inc. $90.39  -1.86%
Merit Medical Systems, Inc. $58.77  -3.40%
Penumbra, Inc. $157.96  -1.47%
Philips $39.65  -2.77%
Stryker $194.44  -1.80%
Teleflex Inc. $301.69  -1.07%
The Medicines Company $26.58  -5.14%


Stay current: Follow Endovascular Today on Twitter @EVToday

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.